GenSight Biologics S.A.
GSGTF
$0.19
-$0.05-20.79%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.85% | 15.64% | 3.04% | -42.40% | 0.85% |
| Total Depreciation and Amortization | 7.85% | -65.06% | -3.03% | -13.39% | -0.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.90% | -67.11% | -3.03% | 133.63% | 0.85% |
| Change in Net Operating Assets | 7.84% | 151.09% | -3.03% | 317.05% | 0.85% |
| Cash from Operations | -7.84% | 56.59% | 3.04% | 22.23% | 0.85% |
| Capital Expenditure | -- | -- | -- | 100.00% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.89% | -1,133.33% | 0.00% | -61.43% | -1.41% |
| Cash from Investing | -7.89% | -1,133.33% | 0.00% | -58.46% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 85.77% | 0.00% | -511.30% | 0.00% |
| Issuance of Common Stock | 0.00% | -77.40% | 0.00% | -70.33% | 0.00% |
| Repurchase of Common Stock | -- | -- | 0.00% | 77.27% | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -108.46% | 0.00% | -60.62% | 0.00% |
| Cash from Financing | 7.89% | -78.18% | -3.04% | -88.16% | -0.85% |
| Foreign Exchange rate Adjustments | 7.14% | 102.65% | 3.06% | -7,522.73% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -20.00% | -- | -- | -- | -- |
| Net Change in Cash | -7.85% | 51.62% | 3.04% | -195.15% | -0.85% |